Filing Details
- Accession Number:
- 0001615774-16-007912
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2016-10-31 16:37:07
- Reporting Period:
- 2016-10-31
- Filing Date:
- 2016-10-31
- Accepted Time:
- 2016-10-31 16:37:07
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1430306 | Tonix Pharmaceuticals Holding Corp. | TNXP | Pharmaceutical Preparations (2834) | 261434750 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1563420 | Seth Lederman | C/O Tonix Pharmaceuticals Holding Corp 509 Madison Ave., Suite 306 New York NY 10022 | Chief Executive Officer | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock, $0.001 Par Value | Acquisiton | 2016-10-31 | 10,000 | $0.00 | 90,815 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Common Stock Purchase Warrant | Acquisiton | 2016-10-31 | 10,000 | $0.00 | 5,000 | $0.63 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 10,000 | 2016-10-31 | 2021-10-31 | No | 4 | P | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock, $0.001 Par Value | 20,000 | Indirect | By 401(k) plan |
| Common Stock, $0.001 Par Value | 31,000 | Indirect | By spouse |
| Common Stock, $0.001 Par Value | 29,167 | Indirect | By Leder Laboratories, Inc. |
| Common Stock, $0.001 Par Value | 29,167 | Indirect | By Starling Pharmaceuticals, Inc |
| Common Stock, $0.001 Par Value | 184,628 | Indirect | By Lederman & Co., LLC |
| Common Stock, $0.001 Par Value | 32,457 | Indirect | By L&L Technologies, LLC |
| Common Stock, $0.001 Par Value | 58,972 | Indirect | By Targent Pharmaceuticals, LLC |
Footnotes
- Included in the purchase of 10,000 Units at a price of $0.55 per Unit. Each Unit consisted of one share of common stock and one warrant exercisable immediately for one-half (0.50) share of common stock at an exercise price of $0.63 per share.
- Reporting person may be deemed to be a control person of this entity.
Billionaire Hedge Funds
